Low Research Lab
News
-
Fluorescence-guided Surgery
Purdue technology used in first fluorescence-guided ovarian cancer surgery Philip Low, the Ralph C. Corely Distinguished Professor of Chemistry who invented the technology, said surgeons were able to see clusters of cancer cells as small as one-tenth of a millimeter, as opposed to the earlier average minimal cluster size of 3 millimeters in diameter based on current methods of visual and tactile detection.
Read release
Watch video: CBS News, ABC News
For information on research and clinicl trials go to On Target, inc.
-
Endocyte, Inc. presents at Meeting
Endocyte, Inc. will present at the 17th International Meeting of the European Society of Gynaecological Oncology (ESGO) West Lafayette, Ind., Sept. 8, 2011 – Endocyte, Inc. (NASDAQ Global Market: ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that a poster about its EC-FV-04 study will be presented at the 17th International Meeting of the European Society of Gynaecological Oncology in Milan, Italy.
Read article (PDF)